Spark Therapeutics CEO Jeff Marrazzo speaks to CNBC’s Meg Tirrell about the biotech company’s hemophilia treatments and the potential for gene therapies.
source CNBC
Spark Therapeutics CEO Jeff Marrazzo On The Future Of Gene Therapy | CNBC
previous post